moxifloxacin has been researched along with bms201038 in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (bms201038) | Trials (bms201038) | Recent Studies (post-2010) (bms201038) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 128 | 13 | 106 |
| Protein | Taxonomy | moxifloxacin (IC50) | bms201038 (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0008 | |
| Microsomal triglyceride transfer protein large subunit | Homo sapiens (human) | 0.0056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darpo, B; Ferber, G; Sager, P; Sumeray, M; Zhou, M | 1 |
1 trial(s) available for moxifloxacin and bms201038
| Article | Year |
|---|---|
Lomitapide at supratherapeutic plasma levels does not prolong the Qtc interval--results from a TQT study with moxifloxacin and ketoconazole.
Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Aza Compounds; Benzimidazoles; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Ketoconazole; Male; Middle Aged; Moxifloxacin; Quinolines; Reference Values; Time Factors; Topoisomerase II Inhibitors; Young Adult | 2013 |